Both Montelukast and M-End DMX offer similar effectiveness, with differences in speed and duration of relief.

Montelukast has fewer side effects and is less likely to interact with other medications.

Both drugs are low-risk for addiction when used properly, with minimal potential for misuse.

Both drugs are easy to use, with clear dosing schedules to ensure treatment adherence.

Both drugs have some contraindications depending on individual health conditions, but neither has major restrictions.

Both drugs are good options depending on the patient’s needs, with Montelukast better for quick relief and M-End DMX for long-term management.